Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Applied Therapeutics Inc’s stock clocked out at $0.48, down -3.20% from its previous closing price of $0.5. In other words, the price has decreased by -$3.20 from its previous closing price. On the day, 1.01 million shares were traded. APLT stock price reached its highest trading level at $0.5038 during the session, while it also had its lowest trading level at $0.4763.
Ratios:
To gain a deeper understanding of APLT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.12.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 69701808 and an Enterprise Value of 41882868. For the stock, the TTM Price-to-Sale (P/S) ratio is 580.88 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 346.139 whereas that against EBITDA is -0.376.
Stock Price History:
The Beta on a monthly basis for APLT is 2.06, which has changed by -0.9221865 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 17.16%, while the 200-Day Moving Average is calculated to be -67.39%.
Shares Statistics:
It appears that APLT traded 1.91M shares on average per day over the past three months and 845670 shares per day over the past ten days. A total of 141.94M shares are outstanding, with a floating share count of 124.18M. Insiders hold about 13.77% of the company’s shares, while institutions hold 61.15% stake in the company. Shares short for APLT as of 1753920000 were 9781001 with a Short Ratio of 5.12, compared to 1751241600 on 18077667. Therefore, it implies a Short% of Shares Outstanding of 9781001 and a Short% of Float of 6.959999999999999.
Earnings Estimates
Applied Therapeutics Inc (APLT) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.45 and -$0.66 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.54, with 3.0 analysts recommending between -$0.32 and -$0.66.
